ARMATA PHARMACEUTICALS, INC. Share-based Payment Arrangement, Expense
ARMATA PHARMACEUTICALS, INC. (ARMP) reported Share-based Payment Arrangement, Expense of $3.39 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-12
- ARMATA PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $3.39M, a 489.74% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $1.07M, a 37.64% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $632.00K, a 78.53% increase year-over-year.
- ARMATA PHARMACEUTICALS, INC. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $622.00K, a 7.16% decline year-over-year.
- ARMATA PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2025 was $2.61M, a 9.78% decline from fiscal 2024.
- ARMATA PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2024 was $2.89M, a 208.42% increase from fiscal 2023.
- ARMATA PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2023 was $938.00K, a 69.79% decline from fiscal 2022.
- ARMATA PHARMACEUTICALS, INC. share-based payment arrangement, expense for fiscal 2022 was $3.10M, a 7.74% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 9 month as first filed | Share-based Payment Arrangement, Expense 12 month | Share-based Payment Arrangement, Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.39M 10-Q · filed 2026-08-12 | $4.47M 10-Q · filed 2026-08-12 | $5.10M derived: sum of 3 quarters · filed 2026-08-12 | $5.72M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | $1.07M 10-Q · filed 2026-05-13 | $1.71M derived: sum of 2 quarters · filed 2026-05-13 | $2.33M derived: sum of 3 quarters · filed 2026-05-13 | $2.90M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | $632.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.25M derived: sum of 2 quarters · filed 2026-03-25 | $1.83M derived: sum of 3 quarters · filed 2026-08-12 | $2.61M 10-K · filed 2026-03-25 | ||||
| 2025-09-30 | $622.00K 10-Q · filed 2025-11-12 | $1.20M derived: sum of 2 quarters · filed 2026-08-12 | $1.98M 10-Q · filed 2025-11-12 | $2.33M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | $575.00K 10-Q · filed 2026-08-12 | $1.36M 10-Q · filed 2026-08-12 | $1.71M derived: sum of 3 quarters · filed 2026-08-12 | $2.38M derived: sum of 4 quarters · filed 2026-08-12 | ||||
| 2025-03-31 | $781.00K 10-Q · filed 2026-05-13 | $1.14M derived: sum of 2 quarters · filed 2026-05-13 | $1.80M derived: sum of 3 quarters · filed 2026-05-13 | $3.14M derived: sum of 4 quarters · filed 2026-05-13 | ||||
| 2024-12-31 | $354.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $1.02M derived: sum of 2 quarters · filed 2026-03-25 | $2.36M derived: sum of 3 quarters · filed 2026-03-25 | $2.89M 10-K · filed 2026-03-25 | ||||
| 2024-09-30 | $670.00K 10-Q · filed 2025-11-12 | $2.00M derived: sum of 2 quarters · filed 2025-11-12 | $2.54M 10-Q · filed 2025-11-12 | $2.73M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $1.33M 10-Q · filed 2025-08-12 | $1.87M 10-Q · filed 2025-08-12 | $2.06M derived: sum of 3 quarters · filed 2025-08-12 | $1.69M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $534.00K 10-Q · filed 2025-05-14 | $727.00K derived: sum of 2 quarters · filed 2025-05-14 | $354.00K derived: sum of 3 quarters · filed 2025-05-14 | $615.00K derived: sum of 4 quarters · filed 2025-05-14 | ||||
| 2023-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-21 | -$180.00K derived: sum of 2 quarters · filed 2025-03-21 | $81.00K derived: sum of 3 quarters · filed 2025-03-21 | $938.00K 10-K · filed 2025-03-21 | ||||
| 2023-09-30 | -$373.00K 10-Q · filed 2024-11-13 | -$112.00K derived: sum of 2 quarters · filed 2024-11-13 | $745.00K 10-Q · filed 2024-11-13 | $1.56M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $261.00K 10-Q · filed 2024-08-13 | $1.12M 10-Q · filed 2024-08-13 | $1.94M derived: sum of 3 quarters · filed 2024-08-13 | $2.78M derived: sum of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | $857.00K 10-Q · filed 2024-05-07 | $1.67M derived: sum of 2 quarters · filed 2024-05-07 | $2.52M derived: sum of 3 quarters · filed 2024-05-07 | $3.47M derived: sum of 4 quarters · filed 2024-05-07 | ||||
| 2022-12-31 | $817.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $1.66M derived: sum of 2 quarters · filed 2024-03-21 | $2.61M derived: sum of 3 quarters · filed 2024-03-21 | $3.10M 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | $846.00K 10-Q · filed 2023-11-14 | $1.79M derived: sum of 2 quarters · filed 2023-11-14 | $2.29M 10-Q · filed 2023-11-14 | $2.95M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $949.00K 10-Q · filed 2023-08-14 | $1.44M 10-Q · filed 2023-08-14 | $2.11M derived: sum of 3 quarters · filed 2023-08-14 | $2.58M derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $493.00K 10-Q · filed 2023-05-11 | $1.16M derived: sum of 2 quarters · filed 2023-05-11 | $1.63M derived: sum of 3 quarters · filed 2023-05-11 | $2.53M derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | $664.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $1.13M derived: sum of 2 quarters · filed 2023-03-16 | $2.04M derived: sum of 3 quarters · filed 2023-03-16 | $2.88M 10-K · filed 2023-03-16 | ||||
| 2021-09-30 | $469.00K 10-Q · filed 2022-11-09 | $1.38M derived: sum of 2 quarters · filed 2022-11-09 | $2.22M 10-Q · filed 2022-11-09 | $3.08M derived: sum of 4 quarters · filed 2022-11-09 | ||||
| 2021-06-30 | $907.00K 10-Q · filed 2022-08-11 | $1.75M 10-Q · filed 2022-08-11 | $2.61M derived: sum of 3 quarters · filed 2022-08-11 | $3.27M derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | $842.00K 10-Q · filed 2022-05-12 | $1.70M derived: sum of 2 quarters · filed 2022-05-12 | $2.37M derived: sum of 3 quarters · filed 2022-05-12 | $3.27M derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $862.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | $1.52M derived: sum of 2 quarters · filed 2022-03-17 | $2.43M derived: sum of 3 quarters · filed 2022-03-17 | $3.48M 10-K · filed 2022-03-17 | ||||
| 2020-09-30 | $663.00K 10-Q · filed 2021-11-10 | $1.57M derived: sum of 2 quarters · filed 2021-11-10 | $2.61M 10-Q · filed 2021-11-10 | $3.66M derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $906.00K 10-Q · filed 2021-08-12 | $1.95M 10-Q · filed 2021-08-12 | $3.00M derived: sum of 3 quarters · filed 2021-08-12 | $5.49M derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | $1.04M 10-Q · filed 2021-05-13 | $2.09M derived: sum of 2 quarters · filed 2021-05-13 | $4.59M derived: sum of 3 quarters · filed 2021-05-13 | $5.31M derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $1.05M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-18 | $3.54M derived: sum of 2 quarters · filed 2021-03-18 | $4.27M derived: sum of 3 quarters · filed 2021-03-18 | $4.27M 10-K · filed 2021-03-18 | ||||
| 2019-09-30 | $2.50M 10-Q · filed 2020-11-12 | $3.22M derived: sum of 2 quarters · filed 2020-11-12 | $3.22M 10-Q · filed 2020-11-12 | $3.32M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $724.00K 10-Q · filed 2020-08-13 | $725.00K 10-Q · filed 2020-08-13 | $822.00K derived: sum of 3 quarters · filed 2020-08-13 | $830.00K derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | $99.00K 10-Q · filed 2019-05-06 | $98.00K derived: sum of 2 quarters · filed 2020-03-19 | $106.00K derived: sum of 3 quarters · filed 2020-03-19 | $119.00K derived: sum of 4 quarters · filed 2020-03-19 | ||||
| 2018-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $7.00K derived: sum of 2 quarters · filed 2020-03-19 | $20.00K derived: sum of 3 quarters · filed 2020-03-19 | $46.00K 10-K · filed 2020-03-19 | $478.00K 10-K · filed 2019-03-25 | |||
| 2018-09-30 | $8.00K 10-Q · filed 2019-11-12 | $120.00K 10-Q · filed 2018-11-08 | $21.00K derived: sum of 2 quarters · filed 2019-11-12 | $47.00K 10-Q · filed 2019-11-12 | $366.00K 10-Q · filed 2018-11-08 | $275.00K derived: sum of 4 quarters · filed 2019-11-12 | ||
| 2018-06-30 | $13.00K 10-Q · filed 2019-08-14 | $124.00K 10-Q · filed 2018-08-09 | $39.00K 10-Q · filed 2019-08-14 | $246.00K 10-Q · filed 2018-08-09 | $267.00K derived: sum of 3 quarters · filed 2019-08-14 | $365.00K derived: sum of 4 quarters · filed 2019-08-14 | ||
| 2018-03-31 | $122.00K 10-Q · filed 2019-05-06 | $254.00K derived: sum of 2 quarters · filed 2019-05-06 | $352.00K derived: sum of 3 quarters · filed 2019-05-06 | $651.00K derived: sum of 4 quarters · filed 2019-05-06 | ||||
| 2017-12-31 | $132.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-25 | $230.00K derived: sum of 2 quarters · filed 2019-03-25 | $529.00K derived: sum of 3 quarters · filed 2019-03-25 | $700.00K 10-K · filed 2019-03-25 | ||||
| 2017-09-30 | $98.00K 10-Q · filed 2018-11-08 | $397.00K derived: sum of 2 quarters · filed 2018-11-08 | $568.00K 10-Q · filed 2018-11-08 | $865.00K derived: sum of 4 quarters · filed 2018-11-08 | ||||
| 2017-06-30 | $299.00K 10-Q · filed 2018-08-09 | $470.00K 10-Q · filed 2018-08-09 | $767.00K derived: sum of 3 quarters · filed 2018-08-09 | $1.10M derived: sum of 4 quarters · filed 2018-08-09 | ||||
| 2017-03-31 | $171.00K 10-Q · filed 2018-05-15 | $468.00K derived: sum of 2 quarters · filed 2018-05-15 | $802.00K derived: sum of 3 quarters · filed 2018-05-15 | $1.35M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | $297.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $631.00K derived: sum of 2 quarters · filed 2018-03-14 | $1.18M derived: sum of 3 quarters · filed 2018-03-14 | $2.00M 10-K · filed 2018-03-14 | ||||
| 2016-09-30 | $334.00K 10-Q · filed 2017-11-14 | $882.00K derived: sum of 2 quarters · filed 2017-11-14 | $1.70M 10-Q · filed 2017-11-14 | $1.93M derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $548.00K 10-Q · filed 2017-08-14 | $462.00K 10-Q · filed 2016-08-15 | $1.36M 10-Q · filed 2017-08-14 | $1.28M 10-Q · filed 2016-08-15 | $1.59M derived: sum of 3 quarters · filed 2017-08-14 | $1.74M derived: sum of 4 quarters · filed 2017-08-14 | ||
| 2016-03-31 | $816.00K 10-Q · filed 2017-05-15 | $1.05M derived: sum of 2 quarters · filed 2017-05-15 | $1.20M derived: sum of 3 quarters · filed 2017-05-15 | $1.25M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | $230.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-27 | $379.00K derived: sum of 2 quarters · filed 2017-03-27 | $431.00K derived: sum of 3 quarters · filed 2017-03-27 | $483.00K 10-K · filed 2017-03-27 | ||||
| 2015-09-30 | $149.00K 10-Q · filed 2016-11-10 | $201.00K derived: sum of 2 quarters · filed 2016-11-10 | $253.00K 10-Q · filed 2016-11-10 | $314.00K derived: sum of 4 quarters · filed 2016-11-10 | ||||
| 2015-06-30 | $52.00K 10-Q · filed 2016-08-15 | $104.00K 10-Q · filed 2016-08-15 | $165.00K derived: sum of 3 quarters · filed 2016-08-15 | $1.57M derived: sum of 4 quarters · filed 2016-08-15 | ||||
| 2015-03-31 | $52.00K 10-Q · filed 2016-05-12 | $113.00K derived: sum of 2 quarters · filed 2016-05-12 | $1.52M derived: sum of 3 quarters · filed 2016-05-12 | $1.76M derived: sum of 4 quarters · filed 2016-05-12 | ||||
| 2014-12-31 | $61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $1.47M derived: sum of 2 quarters · filed 2016-03-30 | $1.70M derived: sum of 3 quarters · filed 2016-03-30 | $1.94M 10-K · filed 2016-03-30 | ||||
| 2014-09-30 | $1.41M 10-Q · filed 2015-11-16 | $1.06M 10-Q · filed 2014-11-14 | $1.64M derived: sum of 2 quarters · filed 2015-11-16 | $1.88M 10-Q · filed 2015-11-16 | $1.59M 10-Q · filed 2014-11-14 | $2.11M derived: sum of 4 quarters · filed 2015-11-16 | ||
| 2014-06-30 | $235.00K 10-Q · filed 2015-08-13 | $265.00K 10-Q · filed 2014-09-12 | $468.00K 10-Q · filed 2015-08-13 | $527.00K 10-Q · filed 2014-09-12 | $700.00K derived: sum of 3 quarters · filed 2015-08-13 | $948.00K derived: sum of 4 quarters · filed 2015-08-13 | ||
| 2014-03-31 | $234.00K 10-Q · filed 2015-05-15 | $262.00K 10-Q · filed 2014-05-20 | $465.00K derived: sum of 2 quarters · filed 2015-05-15 | $713.00K derived: sum of 3 quarters · filed 2015-05-15 | $1.52M derived: sum of 4 quarters · filed 2015-05-15 | |||
| 2013-12-31 | $231.00K derived: 10-Q/A 12 month − 10-Q/A 9 month · filed 2015-04-15 | $479.00K derived: sum of 2 quarters · filed 2015-04-15 | $1.28M derived: sum of 3 quarters · filed 2015-04-15 | $1.44M 10-Q/A · filed 2015-04-15 | ||||
| 2013-09-30 | $248.00K 10-Q/A · filed 2015-04-15 | $1.05M derived: sum of 2 quarters · filed 2015-04-15 | $1.21M 10-Q/A · filed 2015-04-15 | |||||
| 2013-06-30 | $803.00K 10-Q/A · filed 2015-04-15 | $958.00K 10-Q/A · filed 2015-04-15 | ||||||
| 2013-03-31 | $154.00K 10-Q/A · filed 2015-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |